Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ester doai
Reexamination Certificate
2006-09-05
2006-09-05
Saeed, Kamal A. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Ester doai
C514S564000, C560S103000, C560S157000, C564S306000
Reexamination Certificate
active
07101911
ABSTRACT:
Compounds of the formula I, in which M, A1, A2, K1 and K2 have the meanings given in the description are novel effective tryptase inhibitors.
REFERENCES:
patent: 6489327 (2002-12-01), Bär et al.
patent: WO 95/32945 (1995-12-01), None
patent: WO 96/09297 (1996-03-01), None
patent: WO 98/04537 (1998-02-01), None
patent: WO 99/12918 (1999-03-01), None
patent: WO 99/24395 (1999-05-01), None
patent: WO 99/24407 (1999-05-01), None
patent: WO 99/40073 (1999-08-01), None
patent: WO 99/40083 (1999-08-01), None
patent: WO 00/14097 (2000-03-01), None
patent: WO 01/10845 (2001-02-01), None
patent: WO 01/10845 (2001-02-01), None
patent: WO 01/10848 (2001-02-01), None
patent: WO 01/19809 (2001-03-01), None
patent: WO 200119809 (2001-03-01), None
patent: WO 01/46128 (2001-06-01), None
patent: WO 01/46168 (2001-06-01), None
Altana Pharma AG
Goldberg Joshua B.
Kosack Joseph R.
McGee Sheldon M.
Nath & Associates PLLC
LandOfFree
Tryptase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Tryptase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tryptase inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3557789